Eicosanoid Research Foundation
- Assets
- $17.9k
- Revenue
- $265.7k
- Investments
- $0.0
- Employees
- 0
- Location
- Detroit, MI
- Founding
- 04/2006
- Data as of
- 12/2022
- EIN
- 27-0097769
Organization Overview
Eicosanoid Research Foundation is located in Detroit, MI. The organization was established in 2006. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Eicosanoid Research Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Eicosanoid Research Foundation generated $265.7k in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 6.1% each year. All expenses for the organization totaled $332.1k during the year ending 12/2022. While expenses have increased by 9.0% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
THE PRIMARY EXEMPT PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO PROVIDE A FORUM FOR THE DISSEMINATION OF THE LATEST SCIENTIFIC INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE AS IT RELATES TO CANCER, INFLAMATION AND INFLAMATION INDUCED DISEASES SUCH AS CARDIOVASCULAR, DIABETES, PSORIASIS AND ALZHEIMER'S. THIS PURPOSE IS ACCOMPLISHED THROUGH THE ORGANIZATION'S BIENNIAL CONFERENCE. THE EICOSANOID RESEARCH FOUNDATION SPONSORS BIENNIAL CONFERENCES HIGHLIGHTING DATA AT THE CUTTING EDGE OF MEDICAL SCIENCE. DURING THESE CONFERENCES NEW DRUGS AND MEDICATIONS ARE DISCUSSED, DATA ON CLINICAL TRIALS IS EXAMINED AND SCIENTISTS FROM ALL OVER THE WORLD INTERACT TO ENHANCE THEIR COLLABORATIVE RESEARCH EFFORTS. THE GOAL OF THIS MEETING SERIES IS TO PROMOTE THE EXCHANGE OF INFORMATION AND IDEAS AMONG INTERNATIONAL SCIENTISTS OF DIVERSE BACKGROUNDS. THE MAIN PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO RAISE FUNDS TO SPONSOR THE INTERNATIONAL CONFERENCE ON BIOACTIVE LIPIDS IN CANCER,
Describe the Organization's Program Activity:
Part 3 - Line 4a
BIENNIAL BIOACTIVE LIPIDS CONFERENCE: THE ORGANIZATION HELD AN INFORMATIVE AND SUCCESSFUL CONFERENCE IN THE FALL OF 2022 RELATING TO THE DISSEMINATION OF THE LATEST SCIENTIFIC AND MEDICAL INFORMATION ON BIO-ACTIVE LIPIDS IN HEALTH AND DISEASE, INCLUDING CANCER. THIS WAS THE 17TH INTERNATIONAL CONFERENCE SCHEDULED IN NEW ORLEANS, LOUISIANA, USA FROM OCTOBER 30 - NOVEMBER 2, 2022. THE CONFERENCE SUCCESSFULLY PROMOTED THE EXCHANGE OF IDEAS AND THEORIES IN THIS AREA AMONG SCIENTISTS AND MEDICAL PROFESSIONALS AROUND THE WORLD, IN AN EFFORT TO FIND A CURE FOR DIEASE AND THE RESOLUTIN OF IMFLAMMATORY DISEASES.
ANNUAL WAYNE STATE UNIVERSITY LIPIDS SYMPOSIUM: THE WAYNE STATE UNIVERSITY LIPIDS SYMPOSIUM ADDRESSES THE VITAL ROLES OF LIPIDS IN CELLULAR PROCESSES REQUIRED FOR NORMAL PHYSIOLOGICAL FUNCTION. THE 7TH WSU LIPIDS SYMPOSIUM WAS SCHEDULED FOR MAY 13, 2020 IN THE STUDENT BALLROOM ON THE MAIN CAMPUS OF WAYNE STATE UNIVERSITY. DUE TO THE COVID-19 PANDEMIC, THE EVENT WAS CANCELED. THE SYMPOSIUM HAS BEEN SUSPENDED SINCE THAT POINT, BUT IS CURRENTLY EXPECTED TO RESUME IN EITHER 2023 OR 2024. PREVIOUSLY, THE (6TH) WSU LIPIDS SYMPOSIUM WAS HELD IN THE STUDENT CENTER BALLROOM ON THE MAIN CAMPUS OF WAYNE STATE UNIVERSITY ON MAY 7, 2019 AND WAS WELL ATTENDED.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Edward A Dennis PHD Director | Trustee | 1 | $0 |
Lawrence J Marnett PHD Director | Trustee | 1 | $0 |
Charles Serhan PHD Director | Trustee | 3 | $0 |
Gabor J Tigyi MD PHD Director | Trustee | 1 | $0 |
Makoto Arita PHD Director | Trustee | 1 | $0 |
Takehiko Yokomizo MD PHD Director | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $139,190 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $139,190 |
| Total Program Service Revenue | $126,541 |
| Investment income | $17 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $265,748 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $9,765 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $9,034 |
| Office expenses | $5,984 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $25,431 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $204,555 |
| Interest | $564 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $37 |
| All other expenses | $14,627 |
| Total functional expenses | $332,097 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $17,889 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $17,889 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $0 |
| Net assets without donor restrictions | $17,889 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $17,889 |